MedTrace Logo

To Improve the Ability of Early Screening and Diagnosis in Patients With Diabetic Nephropathy

NCT05047471 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2022-05-27

No results posted yet for this study

Summary

This is a large-scale, multi-center, observational study. It is planned to establish a large database of 10,000 patients with type 2 diabetes mellitus to investigate the prevalence, awareness and screening rates of diabetes kidney disease (DKD), and provide real-world data on the efficacy and safety of sodium glucose cotransporter 2 inhibitors (SGLT2i) in patients with type 2 diabetes mellitus (T2DM).

Conditions

  • Diabetic Kidney Disease

Sponsors & Collaborators

  • Yiming Mu

    lead OTHER

Principal Investigators

  • Yimin Mu, MD · The First Medical Center of Chinese PLA General Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-25
Primary Completion
2023-05-31
Completion
2023-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05047471 on ClinicalTrials.gov